Background/Objectives: Primary care access in Alberta, Canada is dictated by geography, attachment, timeliness, continuity, and local service burdening. Physician and primary care delivery in rural communities are subject to travel burden, workforce fragility, and intermittency, while suburban communities have immediate proximity to facilities, but are also challenged by delayed access, low attachment, and fragmented episodic care. These access challenges are echoed in rural and frontier contexts in the United States including the state of Wyoming. In this systematic review and narrative synthesis we investigated if and how care coordination between community pharmacists and family physicians, increases primary care access in rural and suburban Alberta, and how transferable those findings are to rural Wyoming and other similar frontier settings. Methods: We searched PubMed/MEDLINE, Embase, Scopus, CINAHL, and the Cochrane Library using controlled vocabulary and free-text terms to identify English-language peer-reviewed studies and practice-relevant evidence published from 1 January 2010 to 19 April 2026 related to primary care access, rural, suburban and frontier settings, Alberta, Wyoming, community pharmacy, pharmacist prescribing, physician-pharmacist collaboration, medication management, chronic disease care, continuity, and emergency department use. Earlier landmark primary-care, physician-pharmacist collaboration, and medication-safety studies were retained only when necessary for conceptual framing. Results: We screened 34 eligible records for inclusion in the narrative synthesis, and seven official contextual sources were included for jurisdictional interpretation. Strong evidence demonstrates that pharmacists are accessible primary care extenders where community services are coordinated with family physicians through documentation, referral pathways, red-flag protocols, and shared medication plans. The strongest evidence is specific to hypertension, cardiovascular risk reduction, and medication management and chronic disease monitoring. Direct Alberta-Wyoming comparative intervention evidence is limited. Conclusions: Physician-pharmacist coordinated care should be implemented prospectively as a geographically tailored access model, not a physician replacement model, with evaluation of access, continuity, medication safety, emergency department use and equity.

Background/Objectives: Primary-care access in Alberta, Canada, is shaped by geography, attachment, timeliness, continuity, and local service capacity. Rural communities may face travel burden, workforce fragility, and intermittent services, whereas suburban communities may have nearby facilities but still experience delayed access, low attachment, and fragmented episodic care. Rural Wyoming has some similar geographic and workforce constraints, although the jurisdictions differ in financing, regulation, and pharmacist scope. This systematic review and narrative synthesis examined evidence on coordinated community pharmacist–family physician care in rural and suburban Alberta and considered, separately, the contextual relevance of the findings to rural Wyoming and comparable frontier settings. Methods: We searched PubMed/MEDLINE, Embase, Scopus, CINAHL, and the Cochrane Library using controlled vocabulary and free-text terms to identify English-language peer-reviewed studies and practice-relevant evidence published from 1 January 2010 to 19 April 2026. Two authors screened titles/abstracts and full texts and resolved decisions by consensus. Methodological appraisal used design-appropriate Critical Appraisal Skills Programme criteria, and outcome-level certainty was considered using GRADE domains. Results: Thirty-four eligible peer-reviewed or practice-evaluation records were included in the narrative synthesis, and seven official contextual or methodological sources supported jurisdictional interpretation. Evidence was strongest for hypertension, cardiovascular risk reduction, medication management, and chronic disease monitoring. No included study directly compared the same intervention in Alberta and Wyoming; evidence for emergency-department effects and equivalent effectiveness across settings was limited. Conclusions: Coordinated pharmacist–family physician care may extend access to selected medication-related and chronic disease services when supported by documentation, referral, follow-up, and red-flag protocols. Application to Wyoming should be treated as a context-dependent proposition requiring local adaptation and prospective evaluation, not as demonstrated transferability or a substitute for physician-led longitudinal primary care.